US0043971052
© PR Newswire
15.12.2025
ARAY
LISTED
NASDAQ
Accuray announces first phase of comprehensive strategic, operational, and organizational transformation plan; company expects first phase to improve annualized operating profitability by approximately $25 million and set the stage for renewed growth
News Preview
Plan includes organizational realignment, rightsizing of cost structure, outsourcing, and sales enablement in order to enhance competitiveness and support long-term strategy.Workforce optimization actions will affect approximately 15% of the company's employees.Of the expected $25 million of annualized operating profit improvement, approximately $...
Themefolio
Profiler
Peergroup
© PR Newswire
05.11.2025
ARAY
LISTED
NASDAQ
Accuray Reports Fiscal 2026 First Quarter Financial Results
News Preview
MADISON, Wis., Nov. 5, 2025 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the first quarter ended September 30, 2025....
Themefolio
Profiler
Peergroup
© PR Newswire
31.10.2025
ARAY
LISTED
NASDAQ
Accuray Incorporated Reports Inducement Award Under NASDAQ Listing Rules
News Preview
MADISON, Wis., Oct. 31, 2025 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported, as required by NASDAQ Listing Rules, equity inducement awards to Stephen La Neve, the company's new Chief Executive Officer. As a material inducement to Mr. La Neve joining the company, and in accordance with NASDAQ L...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© PR Newswire
28.10.2025
ARAY
LISTED
NASDAQ
Accuray to Report First Quarter Fiscal 2026 Financial Results on November 5, 2025
News Preview
MADISON, Wis., Oct. 28, 2025 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report financial results for the first quarter of fiscal year 2026, ended September 30, 2025, during a conference call hosted by company management at 1:30 p.m. PT/4:30 p.m. ET on November 5, 2025....
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© PR Newswire
20.10.2025
ARAY
LISTED
NASDAQ
Accuray Accelerates Transformation Efforts with Appointment of Experienced Executive Leaders to Drive Performance and Growth
News Preview
Industry Veteran Steve La Neve Named Chief Executive Officer
Suzanne Winter to Retire as President and CEO
Company Appoints Steven F. Mayer as Transformation Board Sponsor
Chan W. Galbato Nominated to Board of Directors...
Themefolio
Profiler
Peergroup
© PR Newswire
08.10.2025
ARAY
LISTED
NASDAQ
Accuray Announces Milestone for Cancer Patients in Melbourne, Australia with First SBRT Treatments Using the CyberKnife® System
News Preview
5D Clinics and Joint Venture Partner Icon Group Make Strides in Delivering on Commitment to Increasing Access to World-class Radiation Treatments for More Communities Across Australia.
MADISON, Wis., Oct. 8, 2025 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARA...
Themefolio
Profiler
Peergroup
© PR Newswire
30.09.2025
ARAY
LISTED
NASDAQ
Accuray and the University of Wisconsin-Madison Announce Memorandum of Understanding to Advance Online Adaptive Radiotherapy in Support of Improving Cancer Patient Care
News Preview
MADISON, Wis., Sept. 30, 2025 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) and the University of Wisconsin School of Medicine and Public Health (UW SMPH) announced today the signing of a memorandum of understanding (MOU) to advance online adaptive radiotherapy (OART) on the Accuray helical radiation treatm...
Themefolio
Profiler
Peergroup
© PR Newswire
26.09.2025
ARAY
LISTED
NASDAQ
Accuray Launches All-in-One Radiotherapy Solution With Advanced Capabilities Designed to Set a New Standard in Cancer Care
News Preview
New Solution Provides an Unprecedented Set of Tools, Empowering Clinical Teams With Choice and Flexibility to Deliver Adaptive Care—Tailoring Radiotherapy to Each Patient's Unique Needs
MADISON, Wis., Sept. 26, 2025 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the company is advancing its legacy of leadership in adapti...
Themefolio
Profiler
Peergroup
© PR Newswire
11.09.2025
ARAY
LISTED
NASDAQ
Accuray to Host Analyst Event at the American Society of Radiation Oncology Meeting on September 29, 2025
News Preview
Event Will Feature Global KOLs Sharing Their Perspectives on the Role of Adaptive Radiotherapy in Radiation Medicine
MADISON, Wis., Sept. 11, 2025 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the company will host a discussion with analysts and investors on Monday, September 29, 2025, in conjunction with the American S...
Themefolio
Profiler
Peergroup
© PR Newswire
13.08.2025
ARAY
LISTED
NASDAQ
Accuray Reports Fourth Quarter and Fiscal 2025 Financial Results
News Preview
Strong Service Growth; Debt Refinancing Complete; Company Issues FY26 Guidance
MADISON, Wis., Aug. 13, 2025 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the fourth quarter and fiscal 2025, ended June 30, 2025....
Themefolio
Profiler
Peergroup
© PR Newswire
30.07.2025
ARAY
LISTED
NASDAQ
Accuray to Report Fourth Quarter Fiscal 2025 Financial Results on August 13, 2025
News Preview
MADISON, Wis., July 30, 2025 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report financial results for the fourth quarter of fiscal year 2025, ended June 30, 2025, during a conference call hosted by company management at 1:30 p.m. PT/4:30 p.m. ET on August 13, 2025....
Themefolio
Profiler
Peergroup
© PR Newswire
30.06.2025
ARAY
LISTED
NASDAQ
Oncology Innovation Just Hit a Turning Point -- Here's What to Watch
News Preview
USA News Group News CommentaryIssued on behalf of Oncolytics Biotech Inc.
VANCOUVER, BC, June 30, 2025 /PRNewswire/ -- USA News Group News Commentary – The oncology landscape is being pulled in two directions. On one hand, U.S. cancer death rates continue to decline. On the other, global cases are expected to rise sharply—while early-onset diagno...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© PR Newswire
30.06.2025
ARAY
LISTED
NASDAQ
Oncology Innovation Just Hit a Turning Point -- Here's What to Watch
News Preview
USA News Group News CommentaryIssued on behalf of Oncolytics Biotech Inc.
VANCOUVER, BC, June 30, 2025 /PRNewswire/ -- USA News Group News Commentary – The oncology landscape is being pulled in two directions. On one hand, U.S. cancer death rates continue to decline. On the other, global cases are expected to rise sharply—while early-onset diagno...
Themefolio
Profiler
Peergroup
© PR Newswire
30.06.2025
ARAY
LISTED
NASDAQ
Oncology Innovation Just Hit a Turning Point -- Here's What to Watch
News Preview
USA News Group News CommentaryIssued on behalf of Oncolytics Biotech Inc.
VANCOUVER, BC, June 30, 2025 /CNW/ -- USA News Group News Commentary – The oncology landscape is being pulled in two directions. On one hand, U.S. cancer death rates continue to decline. On the other, global cases are expected to rise sharply—while early-onset diagnoses in...
Themefolio
Profiler
Peergroup
© PR Newswire
06.06.2025
ARAY
LISTED
NASDAQ
Accuray Announces Convertible Notes Exchange and Refinancing of Existing Credit Facilities
News Preview
MADISON, Wis., June 6, 2025 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today announced that, after an extensive review over the last several months, including the evaluation of numerous potential financing partners, it has entered into privately negotiated agreements with the holders of its existing 3.75% senior convertible notes due 202...
Themefolio
Profiler
Peergroup
© PR Newswire
30.05.2025
ARAY
LISTED
NASDAQ
Accuray to Participate in the Jefferies Global Healthcare Conference 2025
News Preview
MADISON, Wis., May 29, 2025 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today its participation in the Jefferies Global Healthcare Conference 2025. The management team is scheduled to participate in a fireside chat on Wednesday, June 4th, 2025, at 5:30pm EDT/2:30pm PDT....
Themefolio
Profiler
Peergroup
© PR Newswire
07.05.2025
ARAY
LISTED
NASDAQ
Accuray Showcases New Long-Term Data¹ on Benefits of 5 Session Radiotherapy Treatment for Men with Prostate Cancer at ESTRO 2025
News Preview
More than 40 Clinical Studies Using Accuray Technology Presented at ESTRO 2025; Company Highlights Innovation and Educational Symposia
MADISON, Wis., May 7, 2025 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that new data presented at the European Society for Radiotherapy and Oncology (ESTRO) meeting reinforces the benefits...
Themefolio
Profiler
Peergroup
© PR Newswire
05.05.2025
ARAY
LISTED
NASDAQ
Accuray Announces First SRS/SBRT Patient Treatments in Austria With the CyberKnife® System
News Preview
Medical Team's Use of Accuray CyberComm™ Reduced Commissioning Time by Approximately 50 Percent*, Enabling Them to Initiate Patient Treatments Sooner
MADISON, Wis., May 5, 2025 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the CyberKnife® Center Salzburg is the first in Austria to treat patients with the CyberKnife® Sys...
Themefolio
Profiler
Peergroup
© PR Newswire
16.04.2025
ARAY
LISTED
NASDAQ
Accuray to Report Third Quarter Fiscal 2025 Financial Results on April 30, 2025
News Preview
MADISON, Wis., April 16, 2025 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report financial results for the third quarter of fiscal year 2025, ended March 31, 2025, during a conference call hosted by company management at 1:30 p.m. PT/4:30 p.m. ET on April 30, 2025....
Themefolio
Profiler
Peergroup
© PR Newswire
03.04.2025
ARAY
LISTED
NASDAQ
Accuray CyberKnife® Platform Featured in New Studies Showcasing its Benefits in Central Nervous System Tumors Presented at Radiosurgery Society Scientific Meeting
News Preview
Data Also Highlights Continued Clinical Advances Using the CyberKnife System That are Making High Quality Care an Option for People Who Previously Had Limited Choices
MADISON, Wis., April 3, 2025 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that new data on the clinical use of the CyberKnife® System reinforce the device's b...
Themefolio
Profiler
Peergroup
© PR Newswire
12.03.2025
ARAY
LISTED
NASDAQ
Accuray to Participate at 37th Annual Roth Conference
News Preview
MADISON, Wis., March 12, 2025 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today announced its participation in the 37th Annual Roth Conference taking place on March 16 -18, 2025 in Dana Point, California.
Management will pa...
Themefolio
Profiler
Peergroup
© PR Newswire
05.02.2025
ARAY
LISTED
NASDAQ
Accuray Reports Strong Fiscal 2025 Second Quarter Financial Results & Raises Guidance
News Preview
MADISON, Wis., Feb. 5, 2025 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the second quarter ended December 31, 2024.
Key Fiscal Q2 Highlights:
Strong second quarter and first half results...
Themefolio
Profiler
Peergroup
© PR Newswire
23.01.2025
ARAY
LISTED
NASDAQ
Accuray Announces First 100 Patient Treatment Regimens Completed in China Using the Tomo® C Radiation Treatment Delivery System, a CNNC-Accuray Joint Venture Product
News Preview
MADISON, Wis., Jan. 23, 2025 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that Shandong Cancer Hospital and Institute has achieved a milestone with the completion of treatment for 100 patients using the Tomo® C Radiation Treatment Delivery System, a product built in China through the CNNC-Accuray joint venture. Shandong Can...
Themefolio
Profiler
Peergroup
© PR Newswire
23.01.2025
ARAY
LISTED
NASDAQ
Accuray Announces First 100 Patient Treatment Regimens Completed in China Using the Tomo® C Radiation Treatment Delivery System, a CNNC-Accuray Joint Venture Product
News Preview
MADISON, Wis., Jan. 23, 2025 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that Shandong Cancer Hospital and Institute has achieved a milestone with the completion of treatment for 100 patients using the Tomo® C Radiation Treatment Delivery System, a product built in China through the CNNC-Accuray joint venture. Shandong Can...
Themefolio
Profiler
Peergroup
© PR Newswire
22.01.2025
ARAY
LISTED
NASDAQ
Accuray to Report Second Quarter Fiscal 2025 Financial Results on February 5, 2025
News Preview
MADISON, Wis., Jan. 22, 2025 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report financial results for the second quarter of fiscal year 2025, ended December 31, 2024, during a conference call hosted by company management at 1:30 p.m. PT/4:30 p.m. ET on February 5, 2025....
Themefolio
Profiler
Peergroup
© PR Newswire
21.01.2025
ARAY
LISTED
NASDAQ
Leonel Peralta to Join Accuray as Chief Operations Officer
News Preview
MADISON, Wis., Jan. 21, 2025 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that Leonel Peralta is joining the company as Senior Vice President, Chief Operations Officer, effective February 3, 2025. Mr. Peralta will be responsible for leading worldwide manufacturing operations including driving alignment of operations with co...
Themefolio
Profiler
Peergroup
© PR Newswire
13.01.2025
ARAY
LISTED
NASDAQ
Accuray Announces China National Medical Products Administration Approval of the Radixact® SynC™ and CyberKnife® S7™ Systems; Expands on the China Product Portfolio that Includes the Recently Approved Tomo® C System
News Preview
MADISON, Wis., Jan. 13, 2025 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the company's Radixact SynC™ System and CyberKnife® S7™ System have been approved by the Chinese National Medical Products Administration (NMPA). With these approvals medical care teams can provide patients in China the most advanced Accuray radi...
Themefolio
Profiler
Peergroup
© PR Newswire
18.12.2024
ARAY
LISTED
NASDAQ
New Data Indicates the CyberKnife® System Can Provide a Safe and Effective Treatment Option to Control Brainstem Metastases, an Extremely Challenging Location to Treat
News Preview
Study Builds on Extensive Published Literature Highlighting the Benefits of the CyberKnife System in the Treatment of a Wide Range of Neurological Indications
MADISON, Wis., Dec. 18, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today an international retrospective multicenter analysis found that radiosurgery (SRS) and fract...
Themefolio
Profiler
Peergroup
© PR Newswire
26.11.2024
ARAY
LISTED
NASDAQ
Accuray Incorporated Reports Inducement Award Under NASDAQ Listing Rules
News Preview
MADISON, Wis., Nov. 26, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported, as required by NASDAQ Listing Rules, equity inducement awards to Mike Murphy, the company's new Vice President, Corporate Controller. As a material inducement to Mr. Murphy joining the company, and in accordance with NASDAQ Listing Rule 5635(c)(4), th...
Themefolio
Profiler
Peergroup
© PR Newswire
06.11.2024
ARAY
LISTED
NASDAQ
Accuray Reports Fiscal 2025 First Quarter Financial Results
News Preview
Strong Start to Fiscal Year, Raises 2025 Guidance
MADISON, Wis., Nov. 6, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the first quarter ended September 30, 2024.
"We continue to make...
Themefolio
Profiler
Peergroup
© PR Newswire
23.10.2024
ARAY
LISTED
NASDAQ
Accuray to Report First Quarter Fiscal 2025 Financial Results on November 6, 2024
News Preview
MADISON, Wis., Oct. 23, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report financial results for the first quarter of fiscal year 2025, ended September 30, 2024, during a conference call hosted by company management at 1:30 p.m. PT/4:30 p.m. ET on November 6, 2024....
Themefolio
Profiler
Peergroup
© PR Newswire
21.10.2024
ARAY
LISTED
NASDAQ
Accuray Appoints Michael Murphy as VP, Corporate Controller
News Preview
MADISON, Wis., Oct. 21, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that Michael Murphy, CPA has joined the company as Vice President, Corporate Controller. Mr. Murphy will be responsible for leading the global accounting function including corporate tax, regulatory reporting, accounting policies, and risk management,...
Themefolio
Profiler
Peergroup
© PR Newswire
15.10.2024
ARAY
LISTED
NASDAQ
Accuray President and Chief Executive Officer Suzanne Winter Returns from Medical Leave of Absence
News Preview
MADISON, Wis., Oct. 15, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced that, effective as of today, Suzanne Winter has returned from her temporary medical leave and assumed her full duties as President and Chief Executive Officer. Sandeep Chalke, who has served as interim CEO during Ms. Winter's absence, will continue in his p...
Themefolio
Profiler
Peergroup
© PR Newswire
30.09.2024
ARAY
LISTED
NASDAQ
Accuray Celebrates Opening of Genolier Innovation Hub in Switzerland, Initiation of CyberKnife® S7™ System Medical Professional Training
News Preview
Accuray is the first industry partner to open a facility at the Genolier Innovation Hub, created to provide opportunities for clinician-industry collaborations that can help accelerate improvements in patient careNew Accuray CyberComm™ tool was used to significantly reduce the CyberKnife® S7™ System's commissioning time and enable product trainin...
Themefolio
Profiler
Peergroup
© PR Newswire
10.09.2024
ARAY
LISTED
NASDAQ
Gifu Prefectural General Medical Center Achieves Milestone with Treatment of the First Cancer Patients in Japan Using the Accuray Radixact® System and VitalHold™ Solution
News Preview
The Technology Will Play an Important Role in the Hospital's Plan to Expand Patient Access to High Precision Radiation Therapy Treatments
MADISON, Wis., Sept. 10, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that Gifu Prefectural General Medical Center is setting a new standard in cancer care in Japan as the first hosp...
Themefolio
Profiler
Peergroup
© PR Newswire
03.09.2024
ARAY
LISTED
NASDAQ
Accuray President and Chief Executive Officer Suzanne Winter to Take Temporary Medical Leave of Absence
News Preview
MADISON, Wis., Sept. 3, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that President and Chief Executive Officer Suzanne Winter will be taking a temporary medical leave of absence to receive care for a treatable form of cancer, effective immediately. Accuray Senior Vice President and Chief Commercial Officer Sandeep Cha...
Themefolio
Profiler
Peergroup
© PR Newswire
27.08.2024
ARAY
LISTED
NASDAQ
Accuray Receives CE Mark for a New Helical Radiation Delivery System, Accuray Helix™
News Preview
Developed for India and other countries where patient access to care with radiotherapy is challenged and where versatility and ease of use are a high priorityDrives the next phase of company's strategic plan to expand its portfolio of helical radiation therapy delivery systemsMADISON, Wis., Aug. 27, 2024 /PRNewswire/ -- Accuray Incorporated (NASD...
Themefolio
Profiler
Peergroup
© PR Newswire
14.08.2024
ARAY
LISTED
NASDAQ
Accuray Reports Fourth Quarter and Fiscal 2024 Financial Results
News Preview
14% Revenue and 8% Orders Growth in Q4; Company issues FY25 Guidance
MADISON, Wis., Aug. 14, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the fourth quarter and fiscal 2024, ended June 30, 2024....
Themefolio
Profiler
Peergroup
© PR Newswire
13.08.2024
ARAY
LISTED
NASDAQ
Halifax Health in Florida is First in the U.S. to Treat Patients with Cancer Using the Accuray Radixact® Radiation Delivery System and VitalHold™ Technology
News Preview
New Technology Provides Advanced Patient Positioning Capabilities With the Radixact System, Making it Easier to Deliver Fast and Effective Radiotherapy Treatments
MADISON, Wis. and DAYTONA BEACH, Fla., Aug. 13, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) and Halifax Health, in Volusia County, Florida, announced today that the Charles...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
